Home › Targets › WEE1

WEE1 (1 companies · 2 programs)

Companies with an active program directed at WEE1.

Acrivon Therapeutics ACRV

ACR-2316 — Small Cell Lung Cancer Phase 1
ACR-2316 — Non-Small Cell Lung Cancer Phase 1